A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T-CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL
William, B.M., Abbasi, A., Huang, Y., Larbi, R., Giali, R., Yang, L., Brammer, J., Grantier, C., Hoffman, C., Ayyappan, S., Baiocchi, R., Epperla, N., Christian, B., Alinari, L., Maddocks, K., Chung,Том:
37
Журнал:
Hematological Oncology
DOI:
10.1002/hon.150_2631
Date:
June, 2019
Файл:
PDF, 164 KB
2019
File converter
Більше результатів пошуку
More benefits 
